Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.366NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.441NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.416NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.63NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.263NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.135NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.219NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
N.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.208NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.125.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.78 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.159NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.43.5 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.6.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FP.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.74NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.237NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBNNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBJ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.356NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.462NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.147NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.6 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.5 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.4 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.420NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.39.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EK.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.233NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.24NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.320NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.635NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.19 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
N.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AM.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.15 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.113NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used